Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study
General Info
Time period covered
January, 2016 - December, 2017
Data type
Scientific literature
Keywords
Citation
Journal
PLoS Negl Trop Dis
Pages
e0008298
Publication year
2020
Suggested citation
Dubray CL, Sircar AD, Beau de Rochars VM, Bogus J, Direny AN, Ernest JR, Fayette CR, Goss CW, Hast M, O'Brian K, Pavilus GE, Sabin DF, Wiegand RE, Weil GJ, Lemoine JF. Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study. PLoS Negl Trop Dis. 2020; 14(6): e0008298.